Aspire Growth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$670K Sell
2,742
-246
-8% -$57.3K 0.46% 51
2025
Q4
$618K Sell
2,988
-321
-10% -$63.5K 0.43% 51
2025
Q3
$614K Buy
3,309
+12
+0.4% +$2.06K 0.45% 52
2025
Q2
$504K Sell
3,297
-18
-0.5% -$2.77K 0.41% 58
2025
Q1
$521K Sell
3,315
-246
-7% -$38.5K 0.46% 57
2024
Q4
$515K Buy
+3,561
New +$552K 0.5% 53

Other funds holding JNJ

Aspire Growth Partners's JNJ Position: Q1 2026 in Review

Aspire Growth Partners reduced its Johnson & Johnson (JNJ) stake by 8.2% in Q1 2026, selling an estimated $57.3K and leaving 2,742 shares worth $670K. The position accounts for 0.46% of the portfolio, ranked #51.

Aspire Growth Partners first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aspire Growth Partners held 2,742 shares of Johnson & Johnson worth $670K as of Q1 2026.
  • Aspire Growth Partners sold 246 Johnson & Johnson shares in Q1 2026, an estimated $57.3K.
  • Johnson & Johnson made up 0.46% of Aspire Growth Partners's portfolio in Q1 2026, its #51 holding.
  • Aspire Growth Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.